Fintepla and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Fintepla (fenfluramine hydrochloride), especially for people who are female, 10-19 old, also take Ibuprofen, and have Lennox-gastaut syndrome.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Fintepla. It is created by eHealthMe based on reports of 2,612 people who have side effects when taking Fintepla from the FDA, and is updated regularly.

What is Fintepla?

Fintepla has active ingredients of fenfluramine hydrochloride. eHealthMe is studying from 2,613 Fintepla users. Check the latest studies of Fintepla.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,420 drugs and 2,774 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

On Jul, 30, 2026

2,612 people reported to have side effects when taking Fintepla.
Among them, 25 people (0.96%) have Sinusitis - acute.

Among these 25 people:

What is the gender of people who have Sinusitis - acute when taking Fintepla? *

female: 60 %
male: 40 %

What is the age of people who have Sinusitis - acute when taking Fintepla? *

What are other drugs people take besides Fintepla? *

Lamictal: 4 people, 16.00%
Norethindrone Acetate: 4 people, 16.00%
Acetaminophen: 4 people, 16.00%
Diazepam: 4 people, 16.00%
Diphenhydramine Hydrochloride: 4 people, 16.00%
Epidiolex: 4 people, 16.00%
Epinephrine: 4 people, 16.00%
Fish Oil: 4 people, 16.00%
Hydrocortisone: 4 people, 16.00%
Ibuprofen: 4 people, 16.00%

What are other side effects people have besides Sinusitis - acute? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 17 people, 68.00%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 24.00%
Drowsiness: 5 people, 20.00%
Fatigue (feeling of tiredness): 5 people, 20.00%
Hyperhidrosis (abnormally increased sweating): 5 people, 20.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 4 people, 16.00%
Balance Disorder: 4 people, 16.00%
Lactose Intolerance (inability to digest lactose): 4 people, 16.00%
Kidney Stones: 4 people, 16.00%
Fall: 4 people, 16.00%

What are the existing conditions these people have? *

Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 10 people, 40.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 28.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 16.00%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 3 people, 12.00%
Otitis (ear infection): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fintepla and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fintepla:

Fintepla (2,613 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

Browse all side effects of Fintepla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,420 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,774 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenfluramine hydrochloride (the active ingredients of Fintepla) and Fintepla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.